Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression

Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort

(2017) Anick Bérard et al.   BMJ Open

Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study

(2017) Orna Diav-Citrin et al.   Birth Defects Research

On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants: The Prenatal Antidepressant Exposure Syndrome

(2017) Salvatore Gentile   CNS SPECTRUMS

Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

(2016) Lee S. Cohen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data

(2016) Salvatore Gentile et al.   CNS SPECTRUMS

Mirtazapine in pregnancy and lactation – A systematic review

(2016) Mirte Smit et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records

(2016) Irene Petersen et al.   HEALTH TECHNOLOGY ASSESSMENT

Is carbamazepine a human teratogen?

(2016) F.J.E. Vajda et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate

(2016) Rebecca L. Bromley et al.   NEUROLOGY

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies

(2016) Helen Dolk et al.   NEUROLOGY

Genetic and non-genetic animal models for autism spectrum disorders (ASD)

(2016) Zivanit Ergaz et al.   REPRODUCTIVE TOXICOLOGY

Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children

(2016) Takoua Boukhris et al.   JAMA Pediatrics

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

(2016) Krista F. Huybrechts et al.   JAMA Psychiatry

In utero exposure to valproate increases the risk of isolated cleft palate

(2015) Adam Jackson et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort

(2015) LE Grzeskowiak et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome

(2015) Grace Ewing et al.   CLINICAL PHARMACOKINETICS

PATTERNS AND FACTORS ASSOCIATED WITH LOW ADHERENCE TO PSYCHOTROPIC MEDICATIONS DURING PREGNANCY-A CROSS-SECTIONAL, MULTINATIONAL WEB-BASED STUDY

(2015) Angela Lupattelli et al.   DEPRESSION AND ANXIETY

Antipsychotic use in pregnancy

(2015) Jayashri Kulkarni et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pregnancy Outcome Following Maternal Exposure to Mirtazapine

(2015) Ursula Winterfeld et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis

(2015) Ping Shao et al.   PLoS One

The teratogenicity of the newer antiepileptic drugs - an update

(2014) F. J. E. Vajda et al.   ACTA NEUROLOGICA SCANDINAVICA

Pregnancy Outcome Following In Utero Exposure to Lithium: A Prospective, Comparative, Observational Study

(2014) Orna Diav-Citrin et al.   AMERICAN JOURNAL OF PSYCHIATRY

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study

(2014) L Ban et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Prescribing for the pregnant patient

(2014) N. MEHTA et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers

(2014) E. Campbell et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

In utero exposure to levetiracetam vs valproate: Development and language at 3 years of age

(2014) R. Shallcross et al.   NEUROLOGY

IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study

(2014) G. A. Baker et al.   NEUROLOGY

Atypical Antipsychotic Drugs and Pregnancy Outcome

(2013) Frank Habermann et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

(2013) Kimford J Meador et al.   LANCET NEUROLOGY

Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers

(2013) E. Mawhinney et al.   NEUROLOGY

Antidepressant Use During Early Pregnancy and the Risk of Congenital Anomalies

(2013) Catherine Vasilakis-Scaramozza et al.   PHARMACOTHERAPY

Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study

(2013) Mei Peng et al.   PSYCHOPHARMACOLOGY

Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: Cognitive, motor, sensory and behavioral function

(2013) Tanya Rihtman et al.   REPRODUCTIVE TOXICOLOGY

Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study

(2013) D. Rai et al.   BMJ-British Medical Journal

Use of topiramate in pregnancy and risk of oral clefts

(2012) Andrea V. Margulis et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Prenatal Antipsychotic Exposure and Neuromotor Performance During Infancy

(2012) Katrina C. Johnson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Antipsychotic medication and prefrontal cortex activation: A review of neuroimaging findings

(2012) Edith J. Liemburg et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Comparative safety of antiepileptic drugs during pregnancy

(2012) S. Hernandez-Diaz et al.   NEUROLOGY

Preliminary findings of the developmental effects of in utero exposure to topiramate

(2012) Tanya Rihtman et al.   REPRODUCTIVE TOXICOLOGY

Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects

(2011) Martha M. Werler et al.   ANNALS OF EPIDEMIOLOGY

Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine

(2011) C. Cummings et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review

(2011) Cynthia M. Nijenhuis et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses

(2011) Cynthia M. Nijenhuis et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies

(2011) N. Margreth van der Lugt et al.   EARLY HUMAN DEVELOPMENT

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects

(2011) Ditte Mølgaard-Nielsen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

(2011) Torbjörn Tomson et al.   LANCET NEUROLOGY

Final results from 18 years of the International Lamotrigine Pregnancy Registry

(2011) M. C. Cunnington et al.   NEUROLOGY

Fetal Valproate Syndrome: Clinical and Neuro-developmental Features in Two Sibling Pairs

(2010) Arnold L. Christianson et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Early cognitive development in children born to women with epilepsy: A prospective report

(2010) Rebecca L. Bromley et al.   EPILEPSIA

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

(2010) M. Reis et al.   PSYCHOLOGICAL MEDICINE

Atypical antipsychotic use in pregnancy: a retrospective review

(2009) Christina L. Wichman   Archives of Womens Mental Health

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes

(2009) Cynthia L. Harden et al.   EPILEPSIA

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

(2009) Kimberly A. Yonkers et al.   GENERAL HOSPITAL PSYCHIATRY

Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

(2009) Kimford J. Meador et al.   NEW ENGLAND JOURNAL OF MEDICINE

Valproic acid in pregnancy: How much are we endangering the embryo and fetus?

(2009) Asher Ornoy   REPRODUCTIVE TOXICOLOGY

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS

Pregnancy Outcome after In Utero Exposure to Valproate

(2008) Orna Diav-Citrin et al.   CNS DRUGS

Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?

(2008) J S Rao et al.   MOLECULAR PSYCHIATRY

Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register

(2008) S. Hunt et al.   NEUROLOGY

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

(2008) L. B. Holmes et al.   NEUROLOGY

AUTISM SPECTRUM DISORDERS FOLLOWING IN UTERO EXPOSURE TO ANTIEPILEPTIC DRUGS

(2008) R. L. Bromley et al.   NEUROLOGY

Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy

(2008) S. V. Thomas et al.   PEDIATRIC CARDIOLOGY

The outcome of pregnancy following topiramate treatment: A study on 52 pregnancies

(2008) A ORNOY et al.   REPRODUCTIVE TOXICOLOGY

Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review

(2008) S. Gentile   SCHIZOPHRENIA BULLETIN